Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
1.97M 3.42M 864.84K 3.14M 1.35M 2.07M 3.48M 5.77M 6.47M 9.16M 11.43M 13.95M 17.87M 21.37M 27.27M 29.95M 34.57M 36.5M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 17.94K n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a 1.09M 1.09M 1.09M 1.09M 8.6K 17.94K 17.94K -468.5K -527.82K n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a 35.1K 13.16K n/a n/a n/a n/a n/a 6.99K n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6.99K n/a -6.99K n/a n/a n/a n/a
Other Current Assets
165.96K 62.67K n/a 969.29K 270.33K 371.21K n/a n/a 1.61M n/a n/a n/a 102.5K n/a n/a 586.52K 86.92K 222.79K
Total Current Assets
2.14M 3.87M 1.47M 4.11M 1.62M 2.44M 3.87M 7.81M 8.1M 11.7M 14.29M 14.51M 17.97M 21.65M 27.71M 30.54M 34.66M 36.72M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a 9.81K 76.74K 347.71K 408.48K 468.5K 527.82K 495.14K 553.81K 523.59K 555.85K 585.85K 642.16K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a 1.09M 1.09M 1.09M 1.1M 85.34K 365.65K 426.42K 468.5K 527.82K 495.14K 553.81K 523.59K 555.85K 585.85K 642.16K
Total Assets
2.14M 3.87M 1.47M 5.2M 2.71M 3.53M 4.97M 7.9M 8.46M 12.13M 14.76M 15.04M 18.47M 22.2M 28.23M 31.09M 35.25M 37.37M
Account Payables
1.27M 772.5K 1.14M 1.51M 1.18M 695.79K 1.24M 808.93K 590.58K 939.01K 246.69K 871.08K 1.28M 1.09M 854.98K 1.52M 1.93M 572.74K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a -590.58K n/a n/a -947.57K -180.82K -1.09M n/a -1.52M -1.93M -572.74K
Short-Term Debt
3M 2.55M 328.53K 519.39K n/a 126.84K 312.7K 493.42K 190.24K 107.89K 267.64K 626.9K 180.82K 314.71K 303.42K 672.44K 185.69K 296.14K
Other Current Liabilities
-1.27M 6.11K n/a 28.17K n/a n/a 222.74K n/a 144.2K 43.12K n/a -201.97K -180.82K -192.53K n/a -190.18K -185.69K -181.26K
Total Current Liabilities
3M 3.73M 1.68M 2.13M 1.38M 908.69K 1.8M 1.4M 1.14M 1.78M 1.6M 1.5M 1.46M 1.41M 1.45M 2.2M 2.12M 868.88K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
1.27M 1.18M n/a 1.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
1.27M 1.18M n/a 1.61M n/a 781.85K n/a n/a 65.75K 104.46K 152.44K 204.59K 217.35K 253.93K 299.52K 349.2K 398.18K 446.46K
Total Liabilities
4.27M 3.73M 1.68M 2.13M 1.38M 908.69K 1.8M 1.4M 1.21M 1.89M 1.75M 1.7M 1.68M 1.66M 1.74M 2.54M 2.51M 1.32M
Total Debt
3M 2.55M 328.53K 519.39K n/a 126.84K 322.51K 517.76K 255.99K 414.54K 624.53K 831.49K 398.18K 568.64K 797.21K 1.02M 583.87K 742.61K
Common Stock
823.00 21.48K 12.57K 9.39K 5.58K 4.48K 3.08K 2.55K 2.02K 2.02K 2.02K 117.31K 116.39K 116.39K 116.39K 116.39K 116.19K 115.64K
Retained Earnings
-221.28M -219M -216.79M -213.44M -210.97M -208.67M -206.22M -193.47M -191.46M -188.41M -185.56M -185.26M -181.34M -177.31M -171.27M -168.98M -164.6M -160.78M
Comprehensive Income
n/a n/a n/a n/a n/a -1.59M -3.08K n/a -1.59M n/a 0.00 n/a n/a n/a n/a n/a -0.00 n/a
Shareholders Equity
-2.13M 137.69K -211.88K 3.08M 1.33M 2.63M 3.17M 6.5M 7.26M 10.24M 13.01M 13.34M 16.79M 20.54M 26.49M 28.55M 32.73M 36.05M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 17.94K n/a n/a n/a n/a n/a n/a n/a